Seek Labs
PrivateLast Round
Grant
Feb 17, 2026
Total Funding Raised
$15.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Seek Labs operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Grant round in February 2026.
Seek Labs is a biotechnology company that develops next-generation molecular diagnostic systems and programmable CRISPR-based therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seek Labs Comparables
Compare Seek Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alveo Technologies | 79% | |
| Domus Diagnostics | 77% | |
| CrisprBits | 77% |
For institutional investors. Book with your work email.
Seek Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2026 | ||||
| Series B | Aug 18, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Seek Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Weobly One Capital | Series B |
| HomeStake Venture Partners | Series B |
| U.S. Department of Agriculture | Grant |
| UVB Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 47% MoM.
- Jul 25, 2026
Monthly visitors grew 79% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 26, 2026
Seek Labs, Inc. partners with Two2Ten Foundation under an agreement providing up to $3 million to advance preclinical research expanding the Sequence Ablation Therapeutics platform into oncology in Utah on Oct 26th '26.
For institutional investors. Book with your work email.
Seek Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Seek Labs's valuation, stock price, and market status.
Is Seek Labs a public or private company?
Seek Labs is a private company.
What is the current stock price of Seek Labs?
Seek Labs is a private company, so its shares have no public market price. Caplight tracks Seek Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Seek Labs worth (valuation)?
Valuation information for Seek Labs is not publicly available.
Can I buy Seek Labs stock?
Seek Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Seek Labs's last funding round?
Seek Labs's most recent funding round was Grant on February 17, 2026.
Who are the main investors in Seek Labs?
Key investors in Seek Labs include U.S. Department of Agriculture.
Will Seek Labs IPO soon?
No public IPO plans have been announced for Seek Labs.
How can I track Seek Labs secondary market activity?
Caplight tracks bids, offers, and trades in Seek Labs's shares on secondary markets.